#LCSM Advances | Immunotherapy and the Adjuvant Use of Osimertinib

Our panel of medical experts – Dr. Millie Das, Dr. Gilberto Lopes, Dr. Shayma Kazmi, and Dr. Ravi Salgia– plus lung cancer patient advocate, Lindi Campbell discuss immunotherapy and the adjuvant use of osimertinib. 

Get Started Now

Enroll in Course

Learning Objectives

To review and discuss the most up date immunotherapy options in the adjuvant setting in lung cancer

Accreditation Information

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
Amedco LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
Amedco LLC designates this activity for a maximum of 1.00 ANCC contact hours.

Pharmacists and Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 1.00 knowledge-based CPE contact hours.

NOTE: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

 

How This Course Works

This course is an hour video on immunotherapy and the adjuvant use of osimertinib. 

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

A link to the evaluation will be provided at the conclusion of the course.

If you have questions regarding this enduring material activity, please contact us at certificates@amedcoemail.com.

 

Frequently Asked Questions

How do I access my CME/CE Credits?

A link will be provided you to you at the conclusion of the course. You will be asked to fill out a brief evaluation and your certificate will be automatically emailed back to you.

How long do I have access to the course?

This CME course will be available to access until August 2023.

Can I have face to face interaction with Instructor?

No, this is an online self-paced course with video demonstration. However, you are free to connect with the medical experts for each session on social media or contact the team and we will connect you. 

How many credits can I obtain?

Amedco LLC designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM for physicians and 1.00 contact hours for nurses and 1.00 of knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.  

Course Curriculum

  • #LCSM Advances | Learners Notification
    5 minutes
  • #LCSM Advances | Immunotherapy and the Adjuvant Use of Osimertinib
    65 minutes

Get Started Now

Enroll in Course